Biosensors & POCT– category –
-
Biosensors & POCT Weekly Report October 4, 2026
▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 📄 Weekly Report October 04, 2026 (PDF) — Download Weekly Report October 04, 2026 (PDF) — DownloadDownload 🎙 Podcast October 0... -
Wearable Biosensors Predict Imminent Aggressive Behavior in Autistic Youth with 80% Accuracy, Three Minutes in Advance
Artemis ABA (citing JAMA Network Open) USA Overview A study involving 70 psychiatric inpatient youths with autism demonstrated that wrist-worn biosensors could predict aggressive behavior an average of 3 minutes before its onset, achievi... -
Continuous Glucose Monitoring Patterns Identify Cardiometabolic Risk in Non-Diabetic Adults, Diabetes Care Study Reports
Drugs.com USA Overview A study published in *Diabetes Care* reveals that continuous glucose monitor (CGM) patterns are linked to cardiometabolic risk in adults without diabetes. Analyzing data from 1,356 participants using blinded Dexcom... -
AI-Enhanced Photonic Biosensor Achieves High-Precision Glioblastoma Tissue Detection in Ultra-Compact 76μm² Footprint
AZoSensors International Overview Numerical simulations have demonstrated the development of an ultra-compact photonic biosensor integrated with AI, capable of distinguishing glioblastoma (GBM) tissue from surrounding brain tissue with h... -
SKKU Develops Stretchable Sensor Converting Underwater Ultrasound to Neural Signals, Mimicking Dolphin Sonar
Sungkyunkwan University (SKKU) External Affairs Division (PR team) South Korea Overview A research team at Sungkyunkwan University (SKKU) has successfully developed a novel stretchable sensor capable of converting underwater ultrasound d... -
EASD 2026 Study Reveals Continuous Glucose Monitoring Slashes Type 2 Diabetes Mortality by 44% in Real-World Evidence
Next Move Strategy Consulting USA Overview A groundbreaking study presented at EASD 2026 demonstrated that continuous glucose monitoring (CGM) use is associated with a 44% lower all-cause mortality risk at 12 months in adults with Type 2... -
FDA Updates De Novo Classification List, Accelerating Market Entry for Biosensors and Other Novel Low-to-Moderate Risk Devices
FDA USA Overview The FDA has updated its De Novo classification list, a critical pathway for novel medical devices of low to moderate risk, including biosensors. This update reflects ongoing regulatory clearances for innovative technolog... -
Graphene’s Extreme Strength and Conductivity Poised to Revolutionize Biomedical Technologies, Enhancing Biosensors and Drug Delivery
grapheneuses.org Overview Graphene's exceptional mechanical strength (over 100 times stronger than steel), high electrical and thermal conductivity, optical transparency, and impermeability make it a promising material for biomedical tec... -
Liverpool School of Tropical Medicine Launches £4.5M Partnership for Neglected Tropical Diseases, Featuring Wearable Microwave Biosensors
Liverpool School of Tropical Medicine (LSTM) UK Overview The Liverpool School of Tropical Medicine (LSTM) has announced "ENDPOINT," a new £4.5 million partnership funded by UK aid, targeting the elimination of lymphatic filariasis and on... -
Biolinq Shine Receives FDA 510(K) Clearance as First Needle-Free Wearable Biosensor for Glucose, Sleep, and Activity Tracking Without Prescription
Beyond Type 1 USA Overview The FDA has granted 510(K) clearance to Biolinq Shine, making it the first needle-free wearable biosensor capable of tracking glucose, sleep, and activity. This prescription-free device significantly expands ac...
